Monday, April 7, 2014

Sun Pharma to buy Struggling Ranbaxy for $3.2 billion says Sachin Karpe

Sun Pharmaceutical Industries Ltd (SUN.NS) has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner,  Japan's Daiichi Sankyo Co (4568.T), and got Ranbaxy India-made drugs barred from the United State says Sachin Karpe.

No comments:

Post a Comment